Atul Pande

Insider Reports History

Entity
Individual
Location
C/O Axovant Sciences, Inc., 1441 Broadway, 3 Rd Floor, New York, NY
Signature
/s/ Eva Renee Barnett, attorney-in-fact for Atul Pande
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Atul Pande:

Insider Reports Filed by Atul Pande

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IMVT Immunovant, Inc. Dec 2, 2024 1 -$221K 4 Dec 4, 2024 Director
IMVT Immunovant, Inc. Apr 2, 2024 2 $0 4 Apr 4, 2024 Director
KRTX Karuna Therapeutics, Inc. Mar 18, 2024 5 -$6.26M 4 Mar 18, 2024 Director
IMVT Immunovant, Inc. Dec 1, 2023 3 -$491K 4 Dec 5, 2023 Director
KRTX Karuna Therapeutics, Inc. Jun 20, 2023 2 $0 4 Jun 22, 2023 Director
IMVT Immunovant, Inc. Apr 12, 2023 2 $0 4 Apr 14, 2023 Director
IMVT Immunovant, Inc. Sep 30, 2022 1 $84K 4 Oct 4, 2022 Director
IMVT Immunovant, Inc. Aug 17, 2022 2 $0 4 Aug 19, 2022 Director
KRTX Karuna Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 16, 2022 Director
KRTX Karuna Therapeutics, Inc. Feb 1, 2022 3 -$237K 4 Feb 2, 2022 Director
IMVT Immunovant, Inc. Jan 10, 2022 2 $0 4 Jan 12, 2022 Director
KRTX Karuna Therapeutics, Inc. Jan 3, 2022 3 -$286K 4 Jan 3, 2022 Director
KRTX Karuna Therapeutics, Inc. Dec 1, 2021 3 -$279K 4 Dec 2, 2021 Director
KRTX Karuna Therapeutics, Inc. Nov 1, 2021 3 -$302K 4 Nov 3, 2021 Director
KRTX Karuna Therapeutics, Inc. Oct 1, 2021 3 -$262K 4 Oct 1, 2021 Director
KRTX Karuna Therapeutics, Inc. Sep 1, 2021 3 -$255K 4 Sep 1, 2021 Director
IMVT Immunovant, Inc. Aug 13, 2021 1 $39.9K 4 Aug 16, 2021 Director
KRTX Karuna Therapeutics, Inc. Aug 2, 2021 3 -$245K 4 Aug 2, 2021 Director
KRTX Karuna Therapeutics, Inc. Jul 1, 2021 3 -$242K 4 Jul 1, 2021 Director
KRTX Karuna Therapeutics, Inc. Jun 16, 2021 1 $0 4 Jun 23, 2021 Director
KRTX Karuna Therapeutics, Inc. Jun 1, 2021 3 -$239K 4 Jun 1, 2021 Director